CATX - חוב לטווח קצר להון Perspective Therapeutics Inc

This daily price chart for Perspective Therapeutics (CATX) illustrates the price action of an asset whose business relies on partnerships with research centers to develop targeted radiopharmaceuticals. The indicator stands at 0.00, while isotope production and testing have been outsourced to third-party contractors. Steady progress in clinical trials and strict oversight of raw material supplies keep operational risks within acceptable limits.

An investment audit of the issuer requires a precise liquidity assessment before purchasing assets. This metric compares short-term liabilities against equity, identifying the risk of cash flow gaps and the immediate increase in the cost of debt financing. For Perspective Therapeutics (CATX), such calculations are critical, as the costs of strict compliance with radiation standards and waste disposal require a constant reserve. By analyzing the trend of the ratio between short-term liabilities and equity, an investor determines the balance between expansion and solvency.